The potential of virtual reality-based therapy for serious mental disorders
In June of this year, it was announced that the US Food and Drug Administration (FDA) had awarded UK-based OxfordVR an innovative device designation for its gameChangeVR therapy to deliver immersive cognitive behavioral therapy (CBT) for people with schizophrenia and mental illness. other. . The FDA’s Breakthrough Device Program is for medical devices or device-led … Read more